ARL8A Antibodies

Santa Cruz Biotechnology offers a broad range of ARL8A monoclonal antibodies for investigating ARL8A protein function. ARL8A monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ARL8A is a member of the ARF-like small GTPase family and plays a crucial role in intracellular transport and lysosomal function. ARL8A actively participates in regulating lysosome positioning and fusion with other organelles, which is essential for maintaining cellular homeostasis. Understanding ARL8A function provides valuable insights into various diseases, including neurodegenerative disorders and cancer. ARL8A research continues to reveal new aspects of cellular transport mechanisms and their impact on human health. Current studies focus on how ARL8A influences cellular pathways and disease progression. Santa Cruz Biotechnology monoclonal antibodies for ARL8A enable researchers worldwide to advance scientific understanding of cellular transport and disease mechanisms.